Please review the REU projects and research interests of the REU faculty mentors listed below. Select five faculty members with whom you would like to work. There is no guarantee that you will be matched with your top choice, if selected for participation in the program, but every attempt will be made to accommodate your interests.
- Philip Andrews (Biological Chemistry)
Project Title: TBD
Our research focuses on systems analysis and protein structures through mapping protein interactions and how they are modulated by post-translational modifications. A continuing effort of our laboratory has been development and application of computational methods in proteomics and the application of new chemistries and techniques in structural mass spectrometry. Recent work in the Andrews’ laboratory has focused on the molecular architectures of organelles (and how they change with physiology), methods for quantitative proteomics (including phosphoproteome and histone post-translational modifications), approaches to improving interaction maps, computational methods for analysis of proteomics data, and mapping solution-phase changes in protein structure. Our lab collaborates with a number of other groups to elucidate cell control pathways.
One major project has focused on development of new classes of protein crosslinkers with greatly improved characteristics for mapping protein complexes and characterizing unknown protein structures. These tools have been applied to several protein complexes (including Hsp70 complexes, GRASP55, and MLL1) and are being extended to whole mitochondrial and Golgi membrane protein complexes. The long-term goal of this new research project is determine the dynamics of protein interactions in vivo to better understand cell secretion and energetics processes.
- Heather Carlson (Medicinal Chemistry) - Computational Studies of Protein-Ligand Binding
Project Title: Computational Studies of Protein-Ligand Binding
We have created the largest database of protein-ligand complexes, Binding MOAD (Mother of All Databases). We are using a top-down approach to gather all relevant entries from the Protein Databank. Binding MOAD has 9836 entries, composed of 3151 unique protein systems. After painstakingly searching the crystallography literature, we have collected binding affinity data for 2374 complexes. The student will mine the dataset for information about the molecular recognition that governs ligand binding in proteins. The REU student may choose from a number of sub-projects within our overall program of research. Examples of such projects include:
- Writing programs to measure physical properties of the bound complexes in MOAD and comparing the trends to binding affinity data. Others have mined the PDB for trends, but never before has the community been able to compare the trends to learn their true effect on binding affinity. Trends include degree of buried surface, quality of complementary surface matching, and the volume/volume ratio of the ligand to binding site.
- Examining the role of bridging water molecules in the hydrogen - bonding network of the binding site.
- Measuring side-chain reorientation and backbone movement upon binding different ligands.
- Examining receptor flexibility and induced-fit issues by examining collections of the same protein binding different ligands (multiple protein structure, MPS, techniques). We can also use MPS to push ligand discovery into new chemical space to find new substrates or inhibitors with different sizes and shapes or to study allosteric control in proteins. A relevant student project would be to use MPS to determine which amino acids transmit information from one binding site to another. We work closely with fellow REU Faculty Mentor, Prof. Jason Gestwicki, who can validate our predictions. Students with interests in this project would need a strong foundation in mathematics e.g. advanced calculus or differential equations. Prior experience in computer programming is not required.
- Wei Cheng (Pharmaceutical Sciences) - Enzyme Mechanisms of the Hepatitis C Virus NS3 RNA Helicase
Project Title: Enzyme Mechanisms of the Hepatitis C Virus NS3 RNA Helicase
2~3% of world population is chronically infected with the hepatitis C virus (HCV) and HCV infection is the leading cause of liver transplantation in developed countries. As one of the several essential enzymes encoded by the virus for replication, NS3 protein has been one of the actively pursued drug targets. Toward inhibition of NS3 activity in HCV replication, we have recently developed an ultrahigh resolution single-molecule assay of NS3 helicase activity (Science 333: 1746). This assay has allowed us, for the first time, to directly visualize the single-base pair steps of an NS3 helicase in real time as it unzips double-stranded RNA. Currently we have the following projects that are available for strongly motivated REU students: (1) making and purifying fluorescence-tagged NS3 helicase; (2) single-molecule study of fluorescent NS3 protein to determine the oligomeric states of NS3 during its activity. The knowledge gained from these studies will suggest novel and specific targets for inhibition of NS3 activity.
- Beata Chertok (Pharmaceutical Sciences) - Towards remote-control therapeutics for cancer
Project Title: Towards remote-control therapeutics for cancer
Over 1,500 Americans die of cancer every day, despite treatment with currently available therapies. New therapies are urgently needed to combat this devastating disease. Many potent macromolecules (e.g. proteins, genes) have been developed to effectively kill cancer cells in a petri dish. Most of these molecules, however, are unlikely drug candidates. These molecules are either rapidly eliminated from the blood stream, thus failing to reach the tumor, or accumulate in healthy tissues, thereby causing toxicity. What if drug trafficking could be ‘remote controlled’? The ability to direct drugs to the tumor or activate drugs exclusively in tumors could allow for the effective treatment of tumors without toxicity. Toward this goal, our research is focused on development of nano- and micro-therapeutics that can be non-invasively modulated in the body by ‘remote’ physical signals (e.g. magnetics and ultrasound). The biochemical direction of our research involves chemical and biological modification of proteins and genes for assembly with stimuli-responsive drug vehicles. The engineering direction involves synthesis and formulation of new drug vehicles with stimuli-responsive behavior and development of methodologies for their non-contact modulation. Enthusiastic REU students will have an opportunity to work at the interface of biochemistry and material science, formulate stimuli-responsive therapeutics and explore the remote actuation effects in living cells.
- George Garcia (Medicinal Chemistry) - Protein-Protein Interactions in Bacterial Transcription
Project Title: Protein-Protein Interactions in Bacterial Transcription
There are two projects ongoing in our lab. The first involves the study of the RNA polymerase (RNAP) from M. tuberculosis. As part of this project, we are investigating the interactions between RNAP and a regulatory protein, CarD. We are also looking at a few select sigma factors and how they interact with RNAP. In our second project, we are studying a virulence regulating transcription factor, VirF, from S. flexneri. VirF forms a dimer when it activates virulence genes that are critical to bacterial pathogenesis. We are looking at the dimerization of VirF and also at its interaction with RNAP that are both involved in triggering transcription of virulence genes. An REU student could participate in either of these projects, working with a graduate student or postdoc probing these protein-protein interactions.
- Amanda Garner (Medicinal Chemistry) - Chemistry-Inspired Approaches for Studying the Biology of mRNA Translation
Project Title: Chemistry-Inspired Approaches for Studying the Biology of mRNA Translation
Excess body fat accounts for 25-50% of many frequent cancers, including breast, liver, colorectal and pancreatic cancers. As obesity and diabetes have reached global epidemic status, affecting nearly 1 billion and 250 million people, respectively, worldwide, there is a great need to investigate links between these diseases to validate new targets for drug discovery efforts. The research program of the Garner laboratory focuses on targeting mRNA translation initiation, as derangement of this step in protein synthesis has been implicated in both cancer and metabolic diseases. Importantly, this line of investigation should allow us to further understand druggable connections between cancer, obesity and diabetes. To tackle this challenge, the Garner laboratory uses a variety of chemical biological approaches including the development of chemistry-inspired assays, small molecule library screening and cellular imaging, in addition to chemical synthesis. An REU student can expect to be exposed to techniques drawing from organic chemistry, biochemistry and molecular and cellular biology.
- Cora MacAlister (Molecular, Cellular, and Developmental Biology) - The localization and dynamics of extracellular matrix proteins in tomato fertilization
Project Title: The localization and dynamics of extracellular matrix proteins in tomato fertilization
The extracellular matrix is a complex and dynamic compartment that provides structural support and essential signaling functions to the cells it surrounds. The plant extracellular matrix is composed of a complex interlocking system of different polymers including cellulose, the major load bearing polymer; hemicelluloses which reinforce the cellulose fibrils; pectin which helps regulate wall hydration; and a large and diverse group of structural glycoproteins whose function remains poorly understood. The MacAlister lab uses genetic, molecular and imaging techniques in several model plant species to study the role of these cell wall-associated proteins during plant development.
The structure of the cell wall has important physical consequences for cellular function. Consequently, wall composition varies between cell types and taxonomic groups. This project will focus on a small sub-group of cell wall proteins specific to the Solanaceae plant family which includes tomato, potato, pepper, petunia, tobacco, eggplant and other economically important crop plants. Preliminary data indicates that the members of this protein family are expressed in specific tissues during plant development, particularly in the flower. This project will focus on generating fluorescent reporters of gene expression and protein localization for these family members and generating loss of function mutants and characterizing their phenotypes.
- Anna Mapp (Chemistry) - Towards a Molecular-Level Picture of Gene Transcription
Project Title: Towards a Molecular-Level Picture of Gene Transcription
Altered transcriptional patterns are associated with all human diseases, either as a cause or as an effect. For this reason, molecules that interfere with or promote protein-protein interactions within the transcriptional machinery are attractive targets for therapeutic development and as mechanistic probes. Only a handful of such molecules have been reported, however, due in large part to the still-limited understanding of the mechanism of transcriptional regulation. The Mapp lab uses a combination of synthetic, biochemical, and cell biology approaches to develop a molecular-level picture of key protein-protein interactions in transcription initiation and use that information to design small molecules that mimic essential features of transcription factor structure and function. Current REU projects include using in vivo cross-linking to discover key protein-protein interactions that lead to a gene being turned on and using NMR spectroscopy to study the conformational changes in transcriptional proteins induced by small molecule transcriptional activators. An REU student will learn a variety of techniques from organic synthesis to protein expression to protein NMR.
- Zaneta Nikolovska-Coleska (Pathology) - Towards Developing Molecularly Targeted Small Molecule Inhibitors
Project Title: Towards Developing Molecularly Targeted Small Molecule Inhibitors
The research focus of Nikolovska-Coleska’s group is discovery, design and development of small-molecules as new molecularly targeted therapies for cancer. Molecularly targeted therapy is a treatment that aims to interfere with the function of the biological pathway within the cancer cell that is critical to its growth or survival. By targeting a unique characteristic of the tumor, cancer cells will be specifically killed, providing effective cancer treatment with significantly fewer side effects. We use different strategies to identify new hits and lead compounds, such as high throughput screening, virtual screening and structure-based design. One of the current lab focuses is targeting protein-protein interactions involved in programmed cell death and we are working on developing small molecule inhibitors of myeloid cell leukemia-1 (Mcl-1), a potent anti-apoptotic molecule, member of the Bcl-2 family of proteins. Mcl-1 has been found to be overexpressed in both solid and non-solid tumor cell lines and human cancer tissues. Consistent with its anti-apoptotic function, overexpression of Mcl-1 has been associated with tumor initiation, progression and resistance to current anticancer therapies. Our lab has identified several lead compounds and currently we are optimizing these compounds through a structure-based drug discovery approach supported by experimental structural biology, molecular modeling, chemical synthesis, and biochemical and biological in vitro and in vivo evaluation. The second focus of our research is in epigenetics modifications which play an important role in human cancer. Particularly we are interested in protein-protein interactions that underline the histone modifications, specifically histone methylation and elucidating the biological role of histone lysine methyltransferases (HKMases). For this purpose we have biochemically characterized the protein-protein interactions between Dot1L, a K79 specific histone lysine methyltransferases and MLL-fusion proteins using surface plasmon resonance (SPR). Mutagenesis and structural characterization of these protein-protein interactions are underway. By applying a chemical screening approach we have identified molecules that inhibit enzymatic activity of Dot1L. Using these chemical probes as pharmacological tools, we are performing different cell-based functional assays in order to further elucidate and understand the function of Dot1L and its importance in leukemia. The REU student could be involved in either of these two projects based on his/her interest. The REU student will be exposed to and learn a variety of techniques from organic synthesis, complementary biochemical (fluorescence polarization based binding assay, tritium scintillation proximity enzymatic assay) and biophysical assays (SPR and NMR), functional and cell based assays using different human cancer cell lines for validation and characterization of new small molecule inhibitors.
- Bruce Palfey (Biological Chemistry) - Molecular Recognition by Dihydroorotate Dehydrogenases
Project Title: Molecular Recognition by Dihydroorotate Dehydrogenases
Pyrimidines are vital, not only for the synthesis of nucleic acids, but also for the synthesis of complex carbohydrates, glycoproteins, and glycolipids. Pyrimidines are synthesized de novo from aspartate, ammonia, bicarbonate, and ribose in a six-step sequence. Dihydroorotate dehydrogenases (DHODs) catalyze the only redox reaction in de novo pyrimidine biosynthesis. There are three phylogenetic classes of DHODs, but the structures of the active sites are nearly identical in all. We have discovered that, surprisingly, certain hydroxybenzoates inhibit Class 1A DHODs but not other DHODs, despite the near-identity of the ligand binding sites. The origin of this extreme molecular discrimination is at the moment mysterious. Based on our previous kinetic, spectral, calorimetric, and crystallographic studies, we hypothesize that the pK of the phenolic group of the inhibitor is an important determinant of affinity. Therefore, in this project, hydroxybenzoates substituted with fluorine will be synthesized by a sequence using a standard chemical reaction followed by enzymatic hydroxylation. The fluorinated compounds will be tested for binding in spectral titrations with the enzyme and for inhibitory power by steady-state kinetics. The ionization state of the enzyme-inhibitor complex will be determined by 19F_NMR. The rates of association and dissociation of the inhibitor will be determined in stopped-flow experiments. This project will provide a student with a broad range of research experiences, including bacterial growth, protein purification, organic synthesis, transient and steady-state kinetics, and spectroscopy. The results from this project will be an important contribution to our studies on molecular recognition by DHODs.
- Gus R. Rosania (Pharmaceutical Sciences) - Microscopic image-based analysis of small molecule subcellular transport
Project Title: Microscopic image-based analysis of small molecule subcellular transport
Project Description: My laboratory studies the transport of small bioactive molecules within single living cells using a multidisciplinary approach spanning high throughput microscopic imaging, machine vision, biochemical analysis, chemical genomics, mathematical modeling, and cheminformatics. The goal is to elucidate the relationship between the chemical structure of small molecules and their intracellular distribution, while developing methods for optimizing intracellular transport properties of small molecules by introducing chemical modifications into said molecules, to impart favorable subcellular distribution properties. These studies are essential to our understanding of how cells interact with toxins present in the environment, as well as how cells transport nutrients and rid themselves of metabolic waste products. Specific research projects center on studying cellular transport properties of small molecules, and developing methods to quantitatively assess the mass or concentration of small molecules in different subcellular compartments at different times after cells are exposed to chemical agents, as well as visualizing microscopic imaging data. Small molecule transport can be easily and safely monitored semiquantitatively using microscopy. Undergraduate students participating in the REU program will be paired with graduate students in the lab, with whom they will learn the basics of microscopic image acquisition, analysis and display techniques that are used to elucidate the subcellular accumulation of fluorescent drug-like molecules. They will also study the mechanisms by which small molecule drugs can precipitate inside cells, and will study the interaction between drug crystals and biomolecules in the context of drug discovery and development.
- Anna Schwendeman (Medicinal Chemistry) - Optimization of HDL Nanomedicines for Treatment of Heart Disease
Project Title: Optimization of HDL Nanomedicines for Treatment of Heart Disease
High density lipoprotein (HDL or "good" cholesterol) works by removing excess cholesterol from macrophages in plaques and transporting it to the liver for elimination. Artificial HDLs nanomedicines, hyperbolically called “Drano® for the arteries”, are being tested in clinical trials. The HDL is a natural nanoparticle (10 nm in diameter) composed of apolipoprotein A-I and phospholipids. The objective of this research project is to understand how the size and lipid composition of HDL affects its cholesterol binding properties and, therefore, its potency in cell culture and in animals. Undergraduates will examine protein-phospholipid binding efficiency by titration micro-calorimetry and prepare a variety of HDL nanoparticles. HDLs will be analyzed by chromatography, particle sizing methods, gel electrophoresis and microscopy. The affinity of HDL nanoparticles for cholesterol will be determined by micro-calorimetry and fluorescent spectroscopy, and tested in cell culture. Undergraduates will learn a variety of useful research methodologies and participate in designing novel efficacious and safe HDL nanomedicines for treatment of patients with heart disease.
- Emily Scott (Medicinal Chemistry) - Structural and biochemical features defining human drug metabolism
Project Title: Structural and biochemical features defining human drug metabolism
Drugs and other small molecules foreign to the human body are broken down by cytochrome P450 enzymes. The Scott lab works to understand how real-world pharmaceuticals and toxins are cleared in vivo, largely by probing how the structures of individual P450 enzymes do (and don’t) complement different small molecule scaffolds. This work involves generating human P450 enzymes in the laboratory and employing them in diverse biochemical and structural biology experiments. Diverse enzymatic assays are used to determine which P450 enzyme(s) metabolize which drugs, how readily, and how easily this clearance is negatively impacted by other small molecules to which we are exposed. REU students are also exposed to, and may participate in, the application of X-ray crystallography and protein NMR techniques for determining the structures of P450/ligand complexes that iteratively help understand the metabolism of new drugs and redesign existing drugs for improved metabolism.
- David H. Sherman (Medicinal Chemistry) - Marine Microbial Discovery and Analysis
Project Title: Marine Microbial Discovery and Analysis
The efforts of the Sherman laboratory to isolate novel marine bacteria involve field collection of sediments, sponges, and other invertebrates (bryozoans, ascidians, soft corals, tunicates) from the Indo-Pacific and eastern Pacific regions. Sediments provide a rich source of diverse actinomycetes that are yielding new biological activities and natural products. Based on our findings that novel classes of microorganisms that produce important secondary metabolites are being discovered from marine sources, it is clear that there is exciting new information to be learned from these novel organisms at the genetic and biochemical levels. Talented undergraduate students are trained to acquire a diverse set of microbiology skills that include developing new conditions and media for growing diverse forms of marine bacteria. As pure cultures are obtained, their research experience develops to include phylogenetic analysis of the microorganisms using 16S rRNA gene sequence analysis, cell wall composition and fatty acid analysis, menaquinone characterization and genome fingerprinting (RFLP analysis). In addition, those students that are interested in chemical aspects of microbiology participate in large scale culture, extraction, fractionation and purification of biologically active natural products.
- Qiong Yang (Biophysics) - Biophysics of Living Systems
Project Title: Biophysics of Living Systems
Our lab employs interdisciplinary approaches (imaging, microfluidics, modeling) for a quantitative understanding of self-organizing behaviors of single cells and single molecules during early embryo development. By connecting the understanding at the molecule, cellular, and tissue levels, we pin down the physical mechanisms that give rise to collective spatio-temporal patterns that arise from complex interactive networks of cells and molecules through biochemical signals and mechanical forces. Interested students are encouraged to contact me (firstname.lastname@example.org) and to visit our webpage (www.umich.edu/~qiongy) for more details.